Treatment of high-grade glioma in children and adolescents.
about
A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and TreatmentMolecular characteristics of pediatric high-grade gliomasCellular immunotherapy for pediatric solid tumorsNimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivoABT-263 enhances sensitivity to metformin and 2-deoxyglucose in pediatric glioma by promoting apoptotic cell deathAn individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013.Advances in the management of paediatric high-grade glioma.An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration.Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapyThe histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines.Exomic sequencing of four rare central nervous system tumor typesPhase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesAnti-cancer Therapies in High Grade Gliomas.Treatment of children with high grade glioma with nimotuzumab: a 5-year institutional experienceCurrent Trends and Healthcare Resource Usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: A National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor).Pediatric neuro-oncology: current status and future directions.The molecular landscape of pediatric brain tumors in the next-generation sequencing era.Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.Novel Approaches to Apoptosis-Inducing Therapies.RIST: a potent new combination therapy for glioblastoma.Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.Commentary on: "A Multi-Institutional Experience in Pediatric High Grade Glioma".Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.Pediatric glioblastoma: a single institution experience.Secondary Solid Malignancies After High-Grade Glioma Treatment in Pediatric Patients.Next generation sequencing as an aid to diagnosis and treatment of an unusual pediatric brain cancer.Treatment options in newly diagnosed glioblastoma.The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors.H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas.Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells.
P2860
Q26767359-8CEC13D9-9255-451A-98C5-4074D69BAA86Q26785952-02411801-95F4-490F-831E-DF04A6024778Q26860786-6D637897-BE79-4512-8FAA-45EC0D452408Q27014912-73D701C1-83BD-49C2-B7B6-B192F9A76693Q27853322-6E2576DB-8405-4357-B294-F258723C1A49Q28488211-99A66E66-F521-4FC5-AC00-C1EC0347239FQ30845275-8C8F6F03-8622-4BC2-80E5-39FD3C465365Q30870633-CD0301E3-07DF-4D00-943B-B61E3526E1B3Q30929161-A752059A-A9C9-435D-8741-8FFF326122C8Q33753458-83BEFDB5-DDC6-4A5C-A1D3-3E53D8CD54B3Q33779323-00711F5E-242E-4640-897E-53E576146CE6Q34221722-E2CF74A3-A3DD-4AD6-8370-5DC29C8340D9Q34286305-25FD4D3A-680C-44D8-B204-B6D399131E30Q34812560-32291D7C-B851-4EA7-B81D-BD35C4C8C258Q35562745-B9B6C01B-EA39-4B4B-A488-81770FDA6CB6Q35738941-AFBDB9D2-EA8D-403E-BC5C-1B5B4EFC678DQ36644898-2E0E78E8-A941-45C2-988F-4323F80EA6FEQ36810416-FB8C64C5-4354-4381-91DB-5847CA81E5A3Q37038397-383EC059-B1E1-403C-BD4B-1F2B2213265FQ37187676-BAFD6822-3D66-4382-8DCF-2DD23DD40F49Q37190159-3EEFCDB1-F24A-4C7E-8791-5EAFE23099C4Q37213305-73B25DEA-8E44-4207-ABB9-4DC30BDE2625Q37290626-7E92850D-BF16-4795-8144-55B1FE972F65Q37484213-DFEAD3D0-E75A-45A4-86DA-AEDA261B5E24Q37573695-30DD862C-42F6-47A6-829B-4751C8B57B2FQ38035070-61B03C3C-6474-4461-A9DE-1991E77930C6Q38231122-48B2BE01-8748-4CC9-9EA6-C4324B7D470BQ38873292-05C02947-E5F0-4DD6-ADCF-101A7E016CDBQ38936710-C5E46D5B-03B3-4734-8728-D247E65F2861Q38966022-DCAA69AE-5DC3-4D55-960D-B5FAEAC6910BQ39174603-F557E8EC-3A3A-4CF0-AFD4-65A9A029D6BFQ39376191-A98F1B41-6994-4D99-B4C9-E181EF46D3EDQ40107689-75ED8897-472D-4F9C-AEEF-3764FEE2DD6AQ40355125-1B7A2C32-ED85-4D31-825B-818064908807Q41519389-74297442-A0B4-474E-8390-D5CA34398B32Q42242778-DCCAF7DC-76FA-4D8A-A056-DB1F3FC45606Q44532006-9DCD7F78-63E3-4FE4-A56D-4152E016CF26Q47114749-2403C822-4E95-45B2-BCD8-29961C07804EQ47436402-329F19D9-DA08-4A9B-91AF-590B17F30251Q47671054-9F35D4A1-1BEE-46C4-8BEB-7E366D047479
P2860
Treatment of high-grade glioma in children and adolescents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of high-grade glioma in children and adolescents.
@en
Treatment of high-grade glioma in children and adolescents.
@nl
type
label
Treatment of high-grade glioma in children and adolescents.
@en
Treatment of high-grade glioma in children and adolescents.
@nl
prefLabel
Treatment of high-grade glioma in children and adolescents.
@en
Treatment of high-grade glioma in children and adolescents.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of high-grade glioma in children and adolescents.
@en
P2093
D Aguilera
T J MacDonald
P2860
P304
P356
10.1093/NEUONC/NOR092
P577
2011-07-22T00:00:00Z